Skip to content

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Digital Health · The big question

Finding the Sweet Spot: How Texting Boosts Cancer Screening

Leveraging Text Messaging and Behavior Theory to Improve Colorectal Cancer Screening in Federally Qualified Health Centers: Cohort Study.

Editorial illustration for Leveraging Text Messaging and Behavior Theory to Improve Colorectal Cancer Screening in Federally Qualified Health Centers: Cohort Study.
Editorial illustration

Summary

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Medical guidelines recommend that screening begins at age 45, but getting people to actually complete these tests remains a major challenge, especially in medically underserved communities. To find a better way to reach patients, researchers tested whether simple text messages could nudge adults to get screened. The study tracked more than 4,800 patients across two large community health networks in Texas and California that serve vulnerable populations.

Participants were divided into four groups. One group received no text messages, while others received either a single reminder, a three-week series of messages, or a six-week series. Researchers then tracked whether patients completed one of three common screening methods within 90 days. These methods included a traditional colonoscopy or at-home stool tests, specifically the fecal immunochemical test and Cologuard. The results showed that a moderate approach worked best. Patients receiving the three-week text series were significantly more likely to complete their overall screening than those who received no texts, and even a single message provided a slight boost.

Interestingly, sending too many texts seemed to dilute the benefit. The six-week messaging group did not show a significant overall advantage over the group receiving no messages. Researchers suspect this is due to message fatigue, where patients simply tune out frequent notifications. However, texting was uniquely effective for patients using the Cologuard test, making them up to seven times more likely to complete it. While these findings are promising, the researchers caution that the study was limited to two specific health center networks, meaning the exact results might not perfectly generalize to every hospital or community.

Why it matters.

Significant disparities exist in cancer screening, leaving medically underserved populations at a much higher risk for undetected disease. This research demonstrates that relatively simple technology like text messaging can be a highly effective tool for closing that gap in community health centers. By proving that moderate text reminders work exceptionally well for accessible, at-home options like Cologuard, the study offers a practical blueprint for healthcare providers trying to stretch limited resources.

Crucially, the study also provides a warning for public health campaigns: more communication is not automatically better. Overwhelming patients with six weeks of reminders proved no more effective than sending nothing at all. Tailoring the frequency of these nudges is essential to avoid patient burnout. By finding the right balance, clinics can improve screening rates and ultimately save lives, though future research will be needed to see if these specific texting strategies hold up in healthcare settings nationwide.

From the source

The story in numbers.

Adult participants
4,822
Adjusted odds ratio (aOR) for combined screening completion in 3-week SMS group
1.27
aOR for Cologuard screening completion in 3-week SMS group
7.01
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Digital Health

Upgraded medical AI can now request and analyze diverse diagnostic data.

Imagine chatting with a computer program that not only understands your symptoms but can also act like a medical detective. Researchers have developed a specialized artificial intelligence called the Articulate Medical Intelligence Explorer, or AMIE. This system is a large language model, which is a type of AI trained on vast amounts of text to understand and generate human language. Unlike general conversational programs, AMIE is custom-built specifically to hold diagnostic conversations with patients. Recent upgrades have given AMIE a powerful new set of skills. The AI can now handle multimodal medical data, meaning it can process different kinds of information at the same time. Instead of just passively receiving a list of symptoms, the upgraded system can actively ask for specific medical data, interpret those results, and use that combined information to logically think through a potential diagnosis.

Nature Medicine1 min read
Digital Health

New AI Tool Uses Retinal Scans to Detect Multiple Diseases

Researchers have developed a new artificial intelligence system designed to detect multiple diseases just by analyzing images of the eye. Known as Reti-Pioneer, this computer program examines scans of the retina, the light-sensitive tissue at the back of the eye. By reviewing these pictures, the AI can check for signs of several different health conditions all at once. To build this tool, the research team trained the AI using a massive collection of eye images gathered from various healthcare centers, ranging from local community clinics to large, specialized hospitals. This broad mix of data helps ensure the program works well for different types of patients. The creators then tested the system using outside data, confirming that it performs reliably beyond the original images it was trained on. The system has already been put to the test in real healthcare settings. Through an initial pilot study and a silent trial, where the AI ran in the background without affecting patient care, researchers showed that the tool is fast and practical for doctors to use. However, the study does not yet specify exactly which diseases the AI targets, the exact number of patients tested, or the precise accuracy rates of the diagnoses.

Nature Medicine1 min read
Digital Health

Supreme Court Preserves Telehealth Access to Mifepristone for Now

The Supreme Court has decided that mifepristone, a key medication used in medical abortions, can still be prescribed through telehealth and delivered by mail for the time being. This decision reverses a recent ruling by the 5th Circuit Court of Appeals, which had attempted to temporarily block doctors from prescribing the medication remotely. The legal dispute centers on safety protocols known as Risk Evaluation and Mitigation Strategies. Originally, these rules required patients to obtain mifepristone in person, but the Food and Drug Administration lifted those specific restrictions in 2021 to allow remote prescribing. The state of Louisiana is currently challenging this change in court, arguing that allowing doctors to prescribe the drug via telehealth directly undermines the state's strict abortion ban. It is important to note that the current Supreme Court decision is only a temporary measure. The broader case will continue to move its way through the justice system, meaning the ultimate legality of telehealth distribution for mifepristone remains highly uncertain.

STAT News1 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗